We have carried out a comprehensive end-user related global market analysis of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR). This analysis profiled the use of CRISPR over the period January 2015 to May 2018 and covered more than 3,700 examples of the research and clinical-related use of this technique, across 1,650 laboratory organisations. Each of these has been analysed to provide new commercial insights, developments and opportunities in this important field.
This study analysed eight sectors of the global CRISPR market, including laboratory organisations by name and address, CRISPR applications, global region, country, organisation type and others.
The findings of this study provide a comprehensive source of new market information to suppliers in this field and collectively identify a high proportion of current global users of CRISPR over the last three years (January 2015 to May 2018).
This information provides new insights into the use of CRISPR, including recent developments, and enable suppliers to identify new sales prospects (both established and recent users of CRISPR) in the laboratory, across a comprehensive range of clinical and research applications.
Study findings include i) top CRISPR end-users by organisation name and address ii) leading CRISPR market sectors iii) top CRISPR clinical and research application areas segmented across all areas of the market iv) high-growth CRISPR end-users, segmented across all areas of this study v) new or recent users of CRISPR, segmented across all areas of this study and vi) the identification of CRISPR users by global region, country, organisation type and other areas.
Chapter 1 Background and Methodology
This new report is the outcome of an extensive market analysis of 3,700 examples of the use of CRISPR, across 1,650 laboratories globally. Each of these was profiled by organisation name and address, CRISPR application, global region, country, year (Jan 2015 to May 2018) and other areas.
Chapter 2 CRISPR by Global Region
An analysis of the clinical and research use of CRISPR by global region. These are North America, Asia, Europe, South America, Oceania, Central America, Eastern Africa, Middle East, Southern Africa and Western Africa.
Chapter 3 CRISPR by Country
An analysis of the use of CRISPR across 53 countries. These include Germany, USA, UK, South Korea, Canada, Netherlands, France, China, Australia, Denmark, Switzerland, Spain, Japan, Italy and India.
Chapter 4 CRISPR by Application Area
An analysis of the use of CRISPR across 70 research and clinical-related application areas. These include genes, cells, gene expression, gene knockout, viruses, genomes, cancer, mutations, species (e.g. yeast, zebrafish, mice etc), bacteria, clinical, epigenetics, methylation, model systems, crops and others.
Chapter 5 CRISPR by Organisation Type
An analysis of the use of CRISPR across 40 organisation types. These include universities, hospitals, medical centres, companies, institutes, medical universities, agencies and others.
Chapter 6 Top CRISPR Users
An analysis of the top CRISPR users across 1,650 organisations by name and address.
Chapter 7 CRISPR Market Sectors
An analysis of the use of CRISPR across multiple market sectors covered in this study.
Chapter 8 CRISPR High-Growth Users
An analysis of high-growth CRISPR users across 1,650 organisations by name and address.
Chapter 9 CRISPR New/Recent Users
An analysis of new or recent CRISPR users, globally.
Chapter 10 Discussion
This chapter presents a discussion of these findings and identifies new insignts, developments and opportunities in this field.
John Bates Ph. D (Author)
+44 (0)7870 204848